# A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

> **NCT00956202** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 303 (actual)

## Conditions studied

- Influenza
- Swine-origin A/H1N1 Influenza

## Interventions

- **BIOLOGICAL:** Swine A/H1N1 influenza vaccine (split virion, inactivated)
- **BIOLOGICAL:** Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
- **BIOLOGICAL:** Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)

## Key facts

- **NCT ID:** NCT00956202
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956202, "A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00956202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*